Psychoeducational Intervention to Reduce Depressive Symptoms and Strengthen Mother-Infant Bonding
Launched by YASEMIN OZHUNER · Jul 11, 2025
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special program designed to help new mothers feel less depressed after childbirth and to build a stronger, loving connection with their babies. The program uses a caring and supportive approach that focuses on the mother’s emotional well-being and the bond between mother and infant. Researchers want to see if this kind of support can improve mothers' mental health and their relationship with their newborns.
Women who are between 20 and 35 weeks pregnant, over 18 years old, and expecting a healthy baby (weighing more than 2.5 kg) may be eligible to join the study. Participants need to be able to read and hear well, have no mental health conditions, and plan to stay with their baby after birth. If chosen, mothers will take part in interviews and receive this caring support program, helping them during and after pregnancy. The study is currently looking for volunteers who meet these criteria.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • • Women in their 20-35th week of pregnancy,
- • Volunteers,
- • Over 18 years of age,
- • Literate,
- • No visual, hearing or mental disabilities,
- • Having a healthy baby weighing over 2500 grams,
- • Being in the same environment with their baby after birth,
- • Having a healthy fetus on ultrasound will be included in the study.
- Exclusion Criteria:
- • • Those diagnosed with depression or other mental illnesses by a physician,
- • Those taking medication for mental illness,
- • Women who have given birth prematurely,
- • Stillbirth,
- • Those who have not participated in more than one interview will not be included in the study.
About Yasemin Ozhuner
Yasemin Ozhuner is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic solutions, Yasemin leverages extensive expertise in trial design, regulatory compliance, and patient engagement to ensure the successful execution of clinical studies. Her collaborative approach fosters partnerships with healthcare professionals, research institutions, and regulatory bodies, driving the development of groundbreaking therapies across various therapeutic areas. Through meticulous oversight and a patient-centric ethos, Yasemin strives to bring safe and effective treatments to market, ultimately enhancing the quality of care in the healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Eskişehir, , Turkey
Patients applied
Trial Officials
Yasemin Özhüner
Principal Investigator
Eskişehir Vadişehir Family center odunpazarı Turkey
Nebahat Ozerdogan
Study Director
Eskisehir Osmangazi University odunpazarı turkey
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported